Dr. Shrina Duggal, PharmD, BCOP, is a clinical pharmacy specialist in hematology/oncology/BMT at the University of Pittsburgh Medical Center Hillman Cancer Center. She has been working as a clinical pharmacy specialist at UPMC Hillman Cancer Center since 2007 and has experience in both the inpatient and outpatient settings managing patients with hematological malignancies and solid tumors and most recently in the management of patients receiving various immunotherapy agents. Dr. Duggal acts as faculty mentor and adjunct faculty member at West Virginia University School of Pharmacy and holds the position of adjunct faculty member at the University of Pittsburgh School of Pharmacy. She has lectured and taught extensively across the country and holds multiple preceptorships in experiential learning, pharmacy practice, and hematology/oncology/SCT specialty residencies. Dr. Duggal is a member of the Hematology Oncology Pharmacists Association, American College of Clinical Pharmacy, and American Society for Transplantation and Cellular Therapy.

Gerald W. Cowden is a practicing attorney. He has been representing entrepreneurs, high-growth companies, and financial investors for more than 40 years. Mr. Cowden received his BA at Washington and Jefferson College and his JD at the University of Akron School of Law. In addition to his professional career as a Partner at Cowden & Humphrey, he is also a cofounder of a patient advocacy group, the Meredith A. Cowden Foundation. Mr. Cowden is currently or has been a member or a trustee of numerous prominent state and national business associations or committees including the Corporate Sections of the Cleveland and Akron Bar Associations, the Corporation Law Committee and Taxation Law Committee of the Ohio Bar Association, and the American Bar Association. In addition, he has served as a judge in the Ernst & Young Entrepreneur of the Year Program and on many corporate and advisory boards for both clients and nonclients. In 2007, in conjunction with his daughter Meredith and his wife Marti, he cofounded the Meredith A. Cowden Foundation (www.cowdenfoundation.org). The Foundation’s mission is to raise awareness of the impact of leukemia and graft-versus-host disease (GVHD), to fund research for GVHD, and to provide financial support for nonmedical expenses associated with blood cancers. Every year the Cowden Foundation holds the GVHD National Symposium where research physicians present the latest and greatest methods to help patients living with GVHD. In 2019, the Cowden Foundation received the Lifeblood Award from the Leukemia & Lymphoma Society. Most recently, in February 2020, Mr. Cowden received the Public Service Award from the American Society of Transplantation and Cellular Therapy to honor the work of the Cowden Foundation. Mr. Cowden lives in Akron with his wife of 49 years and has two daughters, Margaux and Meredith.

Dr. Navneet Majhail is the Director of the Blood & Marrow Transplant Program at the Taussig Cancer Institute, Cleveland Clinic, and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. He has also previously served as President of the American Society for Transplantation and Cellular Therapy. Dr. Majhail specializes in the care of adult patients receiving blood and marrow transplantation. His research focuses on transplant outcomes, health services and health policy issues in blood and marrow transplantation, and quality of life and late effects in transplant survivors, including patients with graft-versus-host disease. His research has been funded by the Patient Centered Outcomes Research Institute and the National Institutes of Health.